Genmab(GMAB) - 2022 Q4 - Annual Report

Exhibit 99.1 GENMAB 2022 ANNUAL REPORT Table of Contents | MANAGEMENT'S REVIEW | | | --- | --- | | Our Vision | 2 | | Chair's Statement | 2 | | Letter from the CEO | 3 | | 2022 at a Glance | 4 | | Consolidated Key Figures | 6 | | 2023 Outlook | 9 | | Our Strategy | 11 | | Who We Are | 13 | | Business Model | 14 | | Research and Development Capabilities | 15 | | Enhancing Commercialization Capabilities to Bring Our Innovations to Patients | 16 | | Antibody Discovery and Development | 17 | | Products and Tech ...